N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    8.
    发明授权
    N-ureidoalkyl-piperidines as modulators of chemokine receptor activity 有权
    作为趋化因子受体活性的调节剂的N-脲基烷基 - 哌啶

    公开(公告)号:US07351720B2

    公开(公告)日:2008-04-01

    申请号:US10865417

    申请日:2004-06-10

    IPC分类号: A61K31/4535 C07D417/02

    摘要: The present application describes modulators of chemokine receptor activity of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis, including methods of preparing and intermediates thereof.

    摘要翻译: 本申请描述了可用于预防哮喘和其它过敏性疾病以及自身免疫病态如类风湿性关节炎和动脉粥样硬化的式(I)的趋化因子受体活性的调节剂:或其药学上可接受的盐形式,包括制备和 其中间体。

    N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    10.
    发明授权
    N-ureidoalkyl-piperidines as modulators of chemokine receptor activity 有权
    作为趋化因子受体活性的调节剂的N-脲基烷基 - 哌啶

    公开(公告)号:US07550486B2

    公开(公告)日:2009-06-23

    申请号:US11972649

    申请日:2008-01-11

    IPC分类号: A61K31/445 C07D211/14

    摘要: The present application describes modulators of chemokine receptor activity of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis, including methods of preparing and intermediates thereof.

    摘要翻译: 本申请描述了可用于预防哮喘和其它过敏性疾病以及自身免疫病态如类风湿性关节炎和动脉粥样硬化的式(I)的趋化因子受体活性的调节剂:或其药学上可接受的盐形式,包括制备和 其中间体。